Unlocking Opportunities in the Cholestatic Pruritus Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theCholestatic Pruritus Market?
The increasing prevalence of liver diseases is also expected to drive the growth of the cholestatic pruritus market. Cholestatic pruritus is a symptom often associated with liver diseases, particularly those that disrupt bile flow, such as cirrhosis and hepatitis. The growing incidence of liver diseases due to factors like obesity, diabetes, alcohol consumption, and viral infections has made cholestatic pruritus a significant concern in diagnosing and managing liver conditions. In July 2023, the Office for Health Improvement and Disparities reported that hospital admissions for liver disease in England had increased by 22% between 2022 and 2023. As liver diseases continue to rise, the demand for effective treatments for cholestatic pruritus will increase, driving the growth of the market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp
#What Are the Key Projections for the CAGR of the Cholestatic Pruritus Market From 2025 to 2034?
The cholestatic pruritus market has seen strong and consistent growth, expected to rise from $19.20 billion in 2024 to $20.28 billion in 2025 at a CAGR of 5.6%. Contributing factors include a rising prevalence of skin disorders, increased investments in R&D, a growing demand for effective treatments, heightened awareness, and a favorable regulatory environment.
The cholestatic pruritus market is expected to witness strong growth, reaching $24.97 billion by 2029 at a CAGR of 5.3%. Factors contributing to this growth include a growing elderly population, an increasing prevalence of atopic dermatitis and urticaria, a rising incidence of chronic kidney diseases, and a higher occurrence of conditions linked to pruritus. Notable trends include the introduction of new treatment options, strategic partnerships for cholestatic pruritus research, advancements in treatment modalities, the expansion of healthcare facilities, and continued technological innovation.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21140
What Key Market Trends and Innovations Are Shaping the Future of theCholestatic Pruritus Industry?
Leading companies in the cholestatic pruritus market are concentrating on creating innovative solutions, such as oral medications, to enhance symptom management, improve patient adherence, and offer targeted relief by addressing the root causes of bile salt buildup and inflammation. An oral medication for cholestatic pruritus is a liquid treatment formulated to reduce bile acid buildup and ease severe itching in cholestasis patients. For example, in March 2024, Mirum Pharmaceuticals Inc., a biopharmaceutical company based in the US, received FDA approval for LIVMARLI (maralixibat) oral solution to treat cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered ileal bile acid transporter inhibitor has a breakthrough therapy designation for PFIC type 2 and is expected to significantly benefit patients with cholestatic pruritus associated with PFIC, offering a much-needed treatment for rare subtypes.
Which Companies Are Leading the Charge in Expanding theCholestatic Pruritus Market Growth?
Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report
How is the Global Cholestatic Pruritus Market Segemented?
The cholestatic pruritus market covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types
2) By Treatment Type: Medications, Phototherapy, Other Treatment Types
3) By Route Of Administration: Oral, Topical, Injectable
4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare
Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp
Which Geographics are Influencing the Growth of the Cholestatic Pruritus Market?
North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Cholestatic Pruritus Market 2025, By The Business Research Company:
Histoplasmosis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/histoplasmosis-treatment-global-market-report
Intestinal Pseudo-Obstruction Treatment Global Market Report 2025
Small Cell Lung Cancer Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
